Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with multiple sclerosis by a neurologist
- People who are willing to take part in the study voluntarily
- People who are able to walk
- People whose MS-related disability falls within a specific range on a standard scale (EDSS score between 3.0 and 5.5 — confirm with trial site)
- People who are able to read and write
- People who have access to the internet
- People who have not taken part in a formal physiotherapy or rehabilitation program in the past 3 months
Who may not be able to join:
- People who have a bone or joint problem that affects their ability to move
- People who have a psychiatric condition, significant memory or thinking difficulties, or epilepsy, in addition to their MS diagnosis
- People who have blurred vision or other vision problems
- People who are pregnant
- People who have had an MS attack, or who have received steroid treatment, in the 3 months before joining the study
- People who have another condition that affects the immune system, such as an active infection or cancer
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pelin Vural, MSc, Istanbul University-Cerrahpasa Institute of Postgraduate Education
Phone: +905344245350
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Multiple Sclerosis Functional Composite Test (The change between the initial value and the value after 3 months will be evaluated).; Functional Magnetic Resonance Imaging (fMRI) (The change between the initial value and the value after 3 months will be evaluated).; Brain-derived neurotrophic factor (BDNF) assessment (The change between the initial value and the value after 3 months will be evaluated).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.